Purpose We aimed to systematically review recent publications (01/2014–03/2017) with
longitudinal designs allowing for the assessment of the prospective risk of insomnia on new …

Background Although cognitive behavioral therapy (CBT) is considered a promising
adjuvant to pharmacotherapy for treating bipolar disorder (BD), its efficacy is unproven. The …

Background: The current paper includes a systematic search of the literature, a detailed
presentation of the results, and a grading of treatment options in terms of efficacy and …

BackgroundSubjective reports of insomnia and hypersomnia are common in bipolar
disorder (BD). It is unclear to what extent these relate to underlying circadian rhythm …

Background It is known that sleep disturbance has been considered a trait-marker of mood
disorders. However, the role of disruptions in biological rhythms, such as eating, activity, and …

Sleep disturbance and cognitive dysfunction are two domains of impairment during inter-
episode bipolar disorder. Despite evidence demonstrating the importance of sleep for …

Adolescent and young adult cancer survivors (AYACS) are at risk for the development of
insomnia, though it remains vastly undertreated. Limited research has evaluated cognitive …

Background A growing body of evidence points to relationships between insomnia, negative
affect, and paranoid thinking. However, studies are needed to examine (i) whether negative …

Purpose/Background The aim of this study was to evaluate the effects of quetiapine XR and
lithium on actigraphy-measured circadian parameters in patients with bipolar II depression …

Objective: Bipolar disorders (BD) are characterized by sleep disturbances and emotional
dysregulation both during acute episodes and remission periods. We hypothesized that …